PLUS1
2.89
0.02 (0.7%)
0.02 (0.7%)
Upgrade to Real-Time
Afterhours (Closed)
| Volume | 410,353 |
|
|||||
| News | - | ||||||
| Day High | 2.96 | Low High |
|||||
| Day Low | 2.86 | ||||||
| Stock Name | Stock Symbol | Market | Stock Type |
|---|---|---|---|
| Arbutus Biopharma Corporation | ABUS | NASDAQ | Common Stock |
| Price Change | Price Change % | Stock Price | Last Trade
|
|
|---|---|---|---|---|
| 0.02 | 0.7% | 2.89 | 11:27:47 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 2.88 | 2.86 | 2.96 | 2.93 | 2.87 |
| Trades | Stocks Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 3,025 | 410,353 | US$ 2.93 | US$ 1,200,914 | - | 1.85 - 3.64 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 10:29:03 | 30 | US$ 2.89 | USD |
Period:
Draw Mode:
Arbutus Biopharma Corporation Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| US$ 455.18M | 157.50M | 115.87M | US$ 10.99M | US$ - | -0.83 | -5.80 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | US$ - | - | - | 3.80% |
Arbutus Biopharma News
| Date | Time | Source | News Article |
|---|---|---|---|
| 05/1/2023 | 23:32 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 05/1/2023 | 23:30 | GlobeNewswire Inc. | Arbutus Announces 2023 Corporate Objectives and Provides.. |
| 13/12/2022 | 23:32 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 13/12/2022 | 23:30 | GlobeNewswire Inc. | Arbutus Completes Enrollment in its Phase 2a Clinical Trial.. |
| 14/11/2022 | 14:56 | TipRanks | Robert W. Baird Remains a Hold on Arbutus Biopharma (ABUS) |
| 10/11/2022 | 11:25 | TipRanks | Arbutus Biopharma (ABUS) Gets a Buy from Chardan Capital |
| 10/11/2022 | 08:13 | Edgar (US Regulatory) | Quarterly Report (10-q) |
| 10/11/2022 | 04:45 | TipRanks | JMP Securities Sticks to Their Buy Rating for Arbutus.. |
| 09/11/2022 | 23:34 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 09/11/2022 | 23:30 | GlobeNewswire Inc. | Arbutus Reports Third Quarter 2022 Financial Results and.. |
| 08/11/2022 | 23:30 | GlobeNewswire Inc. | Arbutus to Present at Jefferies London Healthcare Conference |
| 05/11/2022 | 07:55 | TipRanks | Chardan Capital Remains a Buy on Arbutus Biopharma (ABUS) |
Historical ABUS Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.60 | 2.96 | 2.60 | 2.80 | 613,473 | 0.29 | 11.15% |
| 1 Month | 2.22 | 2.96 | 2.15 | 2.60 | 926,641 | 0.67 | 30.18% |
| 3 Months | 2.48 | 2.96 | 2.15 | 2.58 | 1,021,468 | 0.41 | 16.53% |
| 6 Months | 2.38 | 2.96 | 1.85 | 2.42 | 884,357 | 0.51 | 21.43% |
| 1 Year | 2.71 | 3.64 | 1.85 | 2.67 | 1,236,724 | 0.18 | 6.64% |
| 3 Years | 3.14 | 9.00 | 0.88 | 3.87 | 2,951,167 | -0.25 | -7.96% |
| 5 Years | 5.40 | 12.60 | 0.81 | 3.90 | 1,925,897 | -2.51 | -46.48% |